Recently in our inbox, from Nigerian designer Samiat Salami of ready-to-wear fashion and homewares line Oya Abeó: a ...

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered ...

(NASDAQ:ABEO) announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) in response to the Biologics License Application (BLA) for pz-cel (prademagene ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Abeona Therapeutics (NASDAQ:ABEO) stock is falling on Tuesday after ...

Law Offices of Howard G. Smith announces an investigation on behalf of Abeona Therapeutics Inc. ("Abeona" or the "Company") (NASDAQ: ABEO) investors concerning the Company's possible violations of ...

The Law Offices of Frank R. Cruz announces an investigation of Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

On April 22, 2024, Abeona Therapeutics, Inc. (NASDAQ:ABEO) announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) in response to the Biologics License ...

CLEVELAND, April 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...